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MR spectroscopyAbstract Background and purpose: The imaging characterization of thyroid nodules is mandatory
to exclude malignancy. The purpose of this study is to evaluate the role of quantitative diffusion
MRI and 1H MR spectroscopy in differentiation between benign and malignant Thyroid nodules.
Methods: From February 2012 to May 2013, prospective study was conducted on 25 patients with
41 thyroid nodules (11 males, 14 females, age range, 16–74 years with mean 45.3 years) collected
from wards and clinics of Internal Medicine and General Surgery Departments, 20 healthy individ-
uals as control cases were included in the study. 1.5-T 1H-MR spectroscopy (at echo-times (TE) 144
and 35 ms) and diffusion-weighted imaging (b value 0, 250 and 1000 s/mm2) were performed and the
results were correlated with histopathological results.
Results: The mean ADC of the malignant thyroid nodules (13 nodules) was 0.59 ± 0.24 ·
103 mm2/s while that of the benign thyroid nodules (28 nodules) was 1.78 ± 0.21 · 103 mm2/s
(p value <0.0001).
Table 1 Descriptive characteristic
nodules (n= 25) and controls (n=
Co
n=
Sex M
F=
Age (range and mean) 20
48
TSH (ulU/ml) (mean + SD) 2.9
ESR 1st hour mm (mean + SD) 7.6
LDH (U/L) (mean + SD) 31
Table 2 Correlation of diffusion W
Histopathology
Benign nodules n= 28 Folli
Aden
Tumors n= 13 Papi
Folli
Med
Ana
90 R. Elshafey et al.Choline is present in all malignant nodules (13 nodules) and two benign nodules (mild elevation)
while absent in 26 other benign nodules. Choline/creatine ratio in malignant nodules ranged from
1.3 to 5.4, while in two benign nodules it was 0.9 and 1.1.
The sensitivity, speciﬁcity, PPV, NPV and overall accuracy of diffusion and MRS in differentiating
benign from malignant thyroid nodules were 100%, 93%, 96%, 100% and 79%, respectively.
Conclusion: MRS and diffusion WI are useful noninvasive diagnostic modalities in differentiation
between benign and malignant thyroid nodules.
 2014 Production and hosting by Elsevier B.V. on behalf of Egyptian Society of Radiology and Nuclear
Medicine.Open access under CC BY-NC-ND license.1. Introduction
Thyroid nodules are a common clinical entity; present in 4–7%
of the general population (1). The vast majority of these nod-
ules are benign, with only 5% of all solitary nodules proving to
be malignant (2).
While the vast majority of these lesions are benign follicular
adenomas, the exclusion of Thyroid malignancy remains a sig-
niﬁcant diagnostic problem (1).
The history and physical examination remain as the diag-
nostic cornerstones in evaluating the patient with a thyroid
nodule and may be suggestive of thyroid carcinoma. A high in-
dex of clinical suspicion is contemplated when the following
clinical features are present in an individual with euthyroid
STN: rapidly growing hard or ﬁxed nodule, with palpable neck
nodes in central or lateral cervical compartments, with hoarse-
ness of voice, or family history of thyroid cancer, or exposure
of head and neck to radiation in childhood (3).
At present, we believe that ﬁne needle aspiration cytology
(FNAC) and ultrasound are the best methods for investigating
Thyroid nodules. However, even in experienced hands there
are cases in which the etiology of the nodule remains uncertain
and surgery has to be performed for diagnostic purposes (4).s of patients with thyroid
20).
ntrol
20
Patients
n= 25
= 9 M= 11
11 F = 14
–65 16–74
45.3
± 2.1 3.2 ± 1.9
25 ± 0.407 75.75 ± 2.285
6.3 ± 14.69 398.1 ± 21.65
I and ADC value with histopat
cular adenoma (n= 9)
omatous nodule (n= 19)
llary carcinoma (n= 8)
cular carcinoma (n= 3)
ullary carcinoma (n= 1)
plastic carcinoma (n= 1)Cytology of biopsies obtained through ﬁne-needle aspira-
tion (FNA), the standard diagnostic modality for thyroid can-
cer, is unable to discriminate benign from malignant follicular
thyroid nodules, which are differentiated only by capsular or
vascular invasion. Therefore, many thyroidectomies are per-
formed simply to exclude the diagnosis of malignancy (5).
In the benign case, the thyroid gland is unnecessarily re-
moved solely for diagnostic purposes. Ex vivo proton MRS
on resected tissue as well as on FNA has been reported to
accurately discriminate malignant thyroid nodules from nor-
mal tissue (6,7).
Routine T1- and T2-weighted (W) magnetic resonance
imaging (MRI) have a limited role in the evaluation of Thyroid
nodules and cannot assess the real functional status of Thyroid
nodules (8–10).
In order to decrease the risk of unnecessary surgery, as well
as the ﬁnancial burden to the community, there is a need for a
new non-invasive pre-surgical diagnostic test. At present pro-
ton magnetic resonance spectroscopy (1H MRS) is being used
to evaluate cancers in many regions of the body, but the neck
poses many technical difﬁculties such as shimming and subject
motion for in vivo spectroscopy (5).
In MR spectroscopy, choline peak was speciﬁcally looked
for. It was seen that the presence or absence of choline peak
correlates very well with the presence or absence of malignant
foci within the nodule (11).
The choline peak at 3.22 ppm is predominantly due to glyc-
erophosphocholine and glycerophosphoethanolamine that
form phospholipids of the cell membranes. The choline con-
tent rises in malignancy because of rapid multiplication and
proliferation of cells. Height of choline peak depends on the
amount and nature of tissue under voxel (11,12).
DWI plays an important role in differentiating benign or
malignant nodules of the Thyroid gland. Reduced ADC values
have been reported for most malignant tumors and are
thought to be due to cellular membranes impeding the mobility
of water protons (9,13).hological results.
Diﬀusion WI Mean ADC value · 103 mm2/s
Mild restricted diﬀusion 1.76 ± 0.15
1.81 ± 0.27
Restricted diﬀusion 0.63 ± 0.32
0.72 ± 0.17
0.59
0.45
Fig. 1 (a–d): Papillary carcinoma of the thyroid. Female patients aged 55-year old complaining of painless swelling in almost midline
part of the neck, difﬁculty in breathing. MRI: shows evidence of 2 well deﬁned homogenously nodules-seen in isthmus of thyroid gland (in
infrahyoid visceral neck space) displaying high SI on T2 WI. Diffusion study revealed: the thyroid isthmus mass shows restricted diffusion
in DWI, mean ADC value = 0.4 · 103 mm2/s (extremely low ADC). MR spectroscopy: revealed choline peak at 3.2 ppm with choline/
creatine ratio 1.5. (a) Axial T2; (b) diffusion WI; (c) ADC map; (d) MR spectroscopy.
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ated thyroid cancer and medullary Thyroid cancer (radiother-
apy and/or chemotherapy) have been unsatisfactory and
therefore new therapies are necessary. In a near future, Tyro-
sine Kinase Inhibitors (TKIs) may open a new era in the radio-
active iodine refractory DTC and advanced MTC patients
treatment (14).
Numerous small molecule tyrosine kinase inhibitors have
been developed and tested in a variety of tumor types. The suc-
cess of these inhibitors hinges on the discovery of appropriate
targets so integral in tumorigenesis that their disruption is cat-
astrophic for the tumor (15). In Thyroid cancer, the targets
that have been best described include the RET/papillary thy-
roid carcinoma (PTC), RAS, and BRAF. Non-overlapping
rearrangement of RET/PTC, and mutations of RAS, BRAF,
and neurotrophic tyrosine kinase receptor 1 (NTRK1) have
been found in w70% of PTC (16).
Limitation of this study is in motions artifacts by movement
of the tumor as a result of swallowing and breathing, magnetic
susceptibility differences between air in the trachea, bone and
thyroid tissues and contamination of the voxel by adjacent fat.
Also the limitation in this study is the small number of
malignant cases which decrease the statistical strength.The objective of this study is to evaluate the role of com-
bined quantitative diffusion MRI and MRS in differentiation
between benign and malignant thyroid nodules.
2. Materials and methods
Approval of Research Ethics Committee (REC) of Tanta Uni-
versity and informed written consent were obtained from all
participants in the study.
From February 2012 to May 2013, prospective study was
conducted on 25 patients collected from wards and clinics of
Internal Medicine and General Surgery Departments, with
41 thyroid nodules (11 males and 14 females, age range, 16–
74 years with mean 45.3 years). 20 healthy individuals were in-
cluded in the study as control group (nine males and 11 fe-
males, age range, 20–65 years with mean 48 years). All
individuals of the study were subjected to: full history taking,
thorough clinical examination and routine laboratory investi-
gations in the form of: CBC, liver and kidney function test,
fasting and 2 h postprandial blood glucose, ESR, LDH,
CRP, and TSH.
All patients were subjected to: U/S on the neck, FNAB,
histopathological examination of the nodules after surgical
Fig. 2 (a–d): Follicular thyroid carcinoma. Female patients aged 28 years complaining of painful swelling in middle and left side of neck,
difﬁculty in swallowing and hoarseness of voice. MRI: shows enlarged both thyroid lobes with large left thyroid lobe lobulated mass
hanging down reaching to the level of suprasternal notch (in infrahyoid visceral neck space), displaying mild heterogeneous SI in T2WI
with areas of high SI denoting cystic changes. Diffusion study revealed: restricted diffusion in DWI. Mean ADC value = 0.1 · 103 mm2/s
(extremely low ADC). MR spectroscopy: revealed choline peak at 3.2 ppm with choline/creatine ratio 1.7. (a) Axial T2; (b) diffusion WI;
(c) ADC map; (d) MR spectroscopy.
92 R. Elshafey et al.removal, preoperative 1.5-T 1H-MR spectroscopy (at echo-
times (TE) 144 and 35 ms) and diffusion-weighted imaging (b
value 250 and 1000 s/mm2).
All MR imaging and 1H-MRS studies were performed
using a 1.5 T system (Signa; GE Medical Systems, Milwaukee,
WI, USA) with neurovascular coil (NV array). The routine
imaging studies included multiplanar T2-weighted fast spin-
echo (4000/126/2) with an echo train length of eight sequences.
Optimal water resonance suppression was achieved. The
parameters used were 2000/270, 192 acquisitions, a spectral
width of 2500 Hz, and 2048 data points for all patients. In
all patients, MR spectra were obtained with a TE of 144 with
additional TE 35. The acquisition time for each sequence was
7 min 54 s.
Fast spin-echo images were transverse T2-weighted MR
images. 1H-MRS was performed by a multivoxel long and
short echo (TE, 144 and 35 ms) point-resolved spatially local-
ized spectroscopy. The area of interest in all patients was thethyroid gland. The section thickness was 20 mm, and the ante-
rior-to-posterior and right-to-left dimensions were
30 · 30 mm.
Metabolites of biologic importance, choline (Cho) and cre-
atine (Cr) were detected by this technique.
The multivoxel MRS data were processed by the spectro-
scopic analysis package on the workstation. The resonances
of main metabolites were quantiﬁed as follows: the Cr peak
at 3.02 ppm, the Cho peak at 3.20 ppm, and the Lac doublet
at 1.33 ppm.
The ratio of Cho/Cr was measured in cases with detected
choline.
2.1. Diffusion-weighted imaging and apparent diffusion
coefﬁcient mapping
Diffusion-weighted imaging was performed in the transverse
plane by using an SE echo-planar imaging sequence with the
Fig. 3 (a–d): Thyroid nodules with Hashimoto’s thyroiditis. Female patient aged 20 years complaining of painless swelling in midline of
the neck. MRI: shows diffuse enlargement in both thyroid lobes (in infrahyoid visceral space of the neck), with multiple bilateral ill-deﬁned
thyroid nodules displaying hyperintense SI in T2 WI. Diffusion study revealed: bilateral areas of mild restricted diffusion in DWI. Mean
ADC value = 2.6 · 103 mm2/s (high ADC). MR spectroscopy: absence of choline peak denoting benign nodule. (a) Axial T2; (b)
diffusion WI; (c) ADC map; MR spectroscopy.
Quantitative diffusion-weighted MRI and 1H MR spectroscopy in differentiation between benign and malignant thyroid nodules 93following parameters: TR/TE/TI (inversion time), 12,000/95/
2200 ms; diffusion gradient encoding in three orthogonal direc-
tions; b= 1000 and 250 s/mm2; FOV, 24 · 40 cm; matrix size,
128 · 256 pixels; section thickness, 5 mm; section gap, 2.5 mm.
An ADCmap was obtained. In the quantitative study, an imag-
ing slice was chosen, ﬁve (1- to 2-cm) circular regions of interest
were located on the thyroid nodule/nodules, meanADC value is
calculated for benign and malignant nodules.
Twenty normal thyroid lobes of control patients were also
evaluated for ADC values.
The sensitivity and the speciﬁcity of DWI, MR spectros-
copy and both techniques are calculated.
The readers of the diffusion WI is blinded to the MRS re-
sults primarily.
Findings were compared with histopathology of thyroid
specimens in all cases.
2.2. Statistical analysis
Statistical presentation and analysis of the present study were
conducted, using the mean and standard deviation by SPSSV.16. Analysis of variance [ANOVA] tests and Tukey’s test
was used to determine the signiﬁcance between two groups:
according to the computer program SPSS for Windows. ANO-
VA test was used for comparison among different times in the
same group in quantitative data. p Value <0.05 was consid-
ered signiﬁcant.
3. Results
Prospective study was conducted on 25 patients (11 males, 14
females, age range, 16–74 years with mean 45.3 years) and 20
healthy individuals as control cases, 14 patients have single
nodule, six patients have two nodules, ﬁve patients have three
nodules with total 41 nodules, 28 nodules were benign (19 ade-
nomatous nodules and nine follicular adenoma), and 13 nod-
ules were malignant (eight papillary carcinomas, three
follicular carcinoma, one medullary carcinoma, and one ana-
plastic carcinoma).
There were four cases with reactive lymph nodes and three
cases of lymph node metastases from lymphoma, anaplastic
carcinoma and medullary carcinoma, the metastatic lymph
Fig. 4 (a–d): A typical thyroid nodule: Male patient aged 30 years complaining of painless swelling in right side of the neck. MRI: shows
right thyroid nodule (in infrahyoid visceral space of the neck) displaying hyperintense SI in T2 WI. Diffusion study revealed: Reveal
restricted diffusion in DWI. Mean ADC value = 1.7 · 103 mm2/s (intermediate ADC). MR spectroscopy: mild choline peak, choline/
creatine ratio 1.1. The patient repeat FNAC after 4 months and no malignancy revealed. (a) Axial T2; (b) diffusion WI; (c) ADC map; (d)
MR spectroscopy.
Table 3 Correlation of choline peak with histopathological
results.
Total Histopathology
Benign (28) Malignant 13
Choline peak present 15 2 13
Choline peak absent 26 26 0
Table 4 Correlation between choline/creatine ratio and his-
topathological results.
Tumor Ch/Cr ratio
Follicular adenoma (n= 2) 0.9, 1.1
Papillary carcinoma (n= 8) 3 ± 1.7
Follicular carcinoma (n= 3) 3.5 ± 2.1
Medullary carcinoma (n= 1) 5.4
Anaplastic carcinoma (n= 1) 5
94 R. Elshafey et al.node characters were the short axis diameter was more than
1 cm, rounded, blurred outline, central degeneration (one
case), heterogeneous enhancement in two cases and marginal
enhancement in one case.
Descriptive characteristics of patients with thyroid nodules
are shown in Table 1.The mean ADC of the malignant thyroid nodules (13 nod-
ules) was 0.59 ± 0.24 · 103 mm2/s while that of the benign
thyroid nodules (28 nodules) was 1.78 ± 0.21 · 103 mm2/s.
The difference between the mean ADC values of benign and
malignant thyroid lesions was statistically signiﬁcant
Table 5 Correlation between combined diffusion WI and MRS and histopathological results.
Diﬀusion WI and MRS Histopathology
Benign Malignant Benign Malignant
Benign nodules (n= 28) 27 1 28
Malignant nodules (n= 13) – 13 – 13
Table 6 Sensitivity, speciﬁcity, PPV, NPV and accuracy of MRS, diffusion study and combined techniques.
Sensitivity Speciﬁcity PPV NPV Accuracy
MRS 96 85 92 92 92
Quantitative diﬀusion 96 92 96 92 95
Diﬀusion and MRS 100 93 96 100 97
Quantitative diffusion-weighted MRI and 1H MR spectroscopy in differentiation between benign and malignant thyroid nodules 95(p< 0.001). No statistically signiﬁcant differences found in
ADC values among the different benign lesions or among
the different malignant lesions at both sequences (Table 2).
The malignant thyroid nodules show extremely low ADC
value (<0.6 · 103 mm2/s) (nine nodules) (Figs. 1 and 2) and
low ADC value (0.6 to <1.2 · 103 mm2/s) (four nodules),
while benign nodules show high ADC value
(>1.8 · 103 mm2/s) (20 nodules) Fig. 3 and intermediate va-
lue (1.2 to <1.8 · 103 mm2/s) (eight nodules) (Fig. 4).
Choline is present in all malignant nodules (13 nodules)
(Figs. 1 and 2) and two benign nodules (Fig. 4) (can be ex-
plained by rapid turnover of cells in a hyperplastic nodule)
while absent in 26 other benign nodules (Fig. 3) and 20 cases
of control group (Table 3).
The choline/creatine ratio of tumors with detectable choline
peak malignant nodules (n= 13) and benign nodules (n= 2)
is shown in Table 4 and Figs. 1, 2 and 4.
Comparison between combined (diffusion WI and MRS)
and histopathological results is shown in Table 5.
The sensitivity, speciﬁcity, positive predictive value, nega-
tive predictive value and accuracy of quantitative diffusion
WI, MR spectroscopy and combined quantitative diffusion
and MRS are shown in Table 6.4. Discussion
Thyroid nodules are the most common disorders of thyroid
gland, more common with increasing age and more frequent
in women; only 3–5% of all nodules are malignant (1,17).
Diffusion-weighted MR imaging has been used to charac-
terize head and neck tumors, in which there are signiﬁcant dif-
ferences in the apparent diffusion coefﬁcient (ADC) values of
malignant tumors and benign lesions (18,19).
In this study, the mean ADC of the malignant thyroid
nodules (13 nodules) was 0.59 ± 0.24 · 103 mm2/s while
that of the benign thyroid nodules (28 nodules) was
1.78 ± 0.21 · 103 mm2/s (signiﬁcant p value <0.0001). This
is in agreement with the study of El-Hariri et al. (20) who stud-
ied on 46 patients with 56 thyroid nodules as the mean ADC of
the benign thyroid nodules in their results was
1.85 ± 0.24 · 103 mm2/s while the mean ADC of the malig-
nant thyroid nodules was 0.89 ± 0.27 · 103 mm2/s. The
ADC values of malignant thyroid nodules were signiﬁcantlylower than the ADC values of benign thyroid nodules (p value
<0.0001).
In the study of Razek et al. (8) the ADC value of
0.98 · 103 mm2/s was the cutoff value differentiating between
benign and malignant nodules while in our study the cutoff va-
lue was 0.8 · 103 mm2/s as highly cellular adenomatous tissue
shows slight low ADC value.
In this study we use b value 0, 250 and 1000 in diffusion
imaging while in the study of Razek et al. (8) who use b-values
of 0, 250, and 500 s/mm2 and they sufﬁce with them to obtain a
high image quality and a high sensitivity for diagnosis of thy-
roid cancer while the use of higher b value reﬂecting the true
diffusion of the tissue.
The study of Gupta et al. (11) who studied on MRS of thy-
roid carcinoma reported that of the 17 benign cases of benign
thyroid nodules, only one showed choline peak; however, all
eight follicular carcinoma cases showed prominent choline
peak. Hence, the sensitivity is 100% while the speciﬁcity is
94.11% this is nearly coinciding with our results as 2 out of
28 cases of benign thyroid nodules show mild choline peak
in MR spectroscopy but do not coincide with them in the sta-
tistical analysis as the sensitivity of MRS in this study was 96%
while the speciﬁcity was 85%.
Elevated Cho is detected in thyroid carcinomas but not in
normal thyroid tissue. Creatine also can be detected frequently
in malignant lesions allowing calculation of Cho/Cr ratios,
which in this study ranged from 1.3 to 5.6 in malignant thyroid
nodules, this is coinciding with the results of Aydin et al. (21)
who studied the role of proton MR spectroscopy and apparent
diffusion coefﬁcient values in the diagnosis of malignant thy-
roid nodules, their results conclude that Cho/Cr ratio for the
malignant nodules was 2.95 ± 1.54–5.30 ± 2.38.
FNA biopsy remains the gold standard for evaluating thy-
roid nodules. Most clinical practice guidelines recommend
FNA biopsy for nodules measuring greater than 1 cm in larg-
est dimension (22).
The false-negative rate for FNA biopsy is 1–3%. The false-
negative rate increases to 10–15% when the nodule is large
(>4 cm) (23).
To determine whether nodules with indeterminate cytology
on FNAB (follicular neoplasm, atypia, etc.) are benign or
malignant without the need for diagnostic surgery, Nikiforov
et al. recently developed a panel of mutations including
BRAF, NRAS, HRAS, KRAS, and two different RET/PTC
96 R. Elshafey et al.rearrangements. The detection of any one of these mutations
was associated with a ﬁnal histopathologic diagnosis of cancer
in 88% of cases with a cytologic diagnosis of atypia and 87%
of cases with cytologic diagnoses of follicular neoplasm/suspi-
cious for a follicular neoplasm (24).
5. Conclusion
Combined MRS and diffusion WI are useful noninvasive diag-
nostic modalities for differentiating between benign and malig-
nant thyroid nodules with excellent results that could be used
instead of FNAB and avoid unuseful thyroidectomy to exclude
malignancy. Elevation of choline and low ADC value can
diagnose malignant thyroid nodules but cannot differentiate
between different types of malignant neoplasm.
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